nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—Lacrimation—Epirubicin—liver cancer	0.0166	0.0203	CcSEcCtD
Neostigmine—Lacrimation—Doxorubicin—liver cancer	0.0154	0.0188	CcSEcCtD
Neostigmine—Paralysis—Epirubicin—liver cancer	0.0141	0.0172	CcSEcCtD
Neostigmine—Nystagmus—Epirubicin—liver cancer	0.0137	0.0167	CcSEcCtD
Neostigmine—Urinary tract disorder—Sorafenib—liver cancer	0.0131	0.016	CcSEcCtD
Neostigmine—Connective tissue disorder—Sorafenib—liver cancer	0.013	0.0159	CcSEcCtD
Neostigmine—Urethral disorder—Sorafenib—liver cancer	0.013	0.0159	CcSEcCtD
Neostigmine—Paralysis—Doxorubicin—liver cancer	0.013	0.0159	CcSEcCtD
Neostigmine—Nystagmus—Doxorubicin—liver cancer	0.0126	0.0155	CcSEcCtD
Neostigmine—Flushing—Sorafenib—liver cancer	0.0123	0.015	CcSEcCtD
Neostigmine—Mediastinal disorder—Sorafenib—liver cancer	0.012	0.0146	CcSEcCtD
Neostigmine—Arrhythmia—Sorafenib—liver cancer	0.0119	0.0145	CcSEcCtD
Neostigmine—Mental disorder—Sorafenib—liver cancer	0.0116	0.0142	CcSEcCtD
Neostigmine—Cardiovascular disorder—Epirubicin—liver cancer	0.0111	0.0136	CcSEcCtD
Neostigmine—Muscle spasms—Sorafenib—liver cancer	0.0111	0.0136	CcSEcCtD
Neostigmine—Lacrimation increased—Epirubicin—liver cancer	0.0106	0.0129	CcSEcCtD
Neostigmine—Syncope—Sorafenib—liver cancer	0.0104	0.0127	CcSEcCtD
Neostigmine—Dysarthria—Epirubicin—liver cancer	0.0103	0.0126	CcSEcCtD
Neostigmine—Cardiovascular disorder—Doxorubicin—liver cancer	0.0103	0.0126	CcSEcCtD
Neostigmine—Loss of consciousness—Sorafenib—liver cancer	0.0102	0.0124	CcSEcCtD
Neostigmine—Atrioventricular block—Epirubicin—liver cancer	0.0101	0.0123	CcSEcCtD
Neostigmine—Arthralgia—Sorafenib—liver cancer	0.00983	0.012	CcSEcCtD
Neostigmine—Lacrimation increased—Doxorubicin—liver cancer	0.0098	0.012	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00976	0.0119	CcSEcCtD
Neostigmine—Dry mouth—Sorafenib—liver cancer	0.00962	0.0117	CcSEcCtD
Neostigmine—Dysarthria—Doxorubicin—liver cancer	0.00955	0.0117	CcSEcCtD
Neostigmine—Salivary hypersecretion—Epirubicin—liver cancer	0.00948	0.0116	CcSEcCtD
Neostigmine—Anaphylactic shock—Sorafenib—liver cancer	0.00943	0.0115	CcSEcCtD
Neostigmine—Atrioventricular block—Doxorubicin—liver cancer	0.00931	0.0114	CcSEcCtD
Neostigmine—Shock—Sorafenib—liver cancer	0.00927	0.0113	CcSEcCtD
Neostigmine—Nervous system disorder—Sorafenib—liver cancer	0.00924	0.0113	CcSEcCtD
Neostigmine—Skin disorder—Sorafenib—liver cancer	0.00916	0.0112	CcSEcCtD
Neostigmine—Coma—Epirubicin—liver cancer	0.00892	0.0109	CcSEcCtD
Neostigmine—Salivary hypersecretion—Doxorubicin—liver cancer	0.00877	0.0107	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00859	0.0105	CcSEcCtD
Neostigmine—Dyspnoea—Sorafenib—liver cancer	0.0084	0.0103	CcSEcCtD
Neostigmine—Coma—Doxorubicin—liver cancer	0.00825	0.0101	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00814	0.00994	CcSEcCtD
Neostigmine—Gastrointestinal pain—Sorafenib—liver cancer	0.00771	0.00942	CcSEcCtD
Neostigmine—Urticaria—Sorafenib—liver cancer	0.00749	0.00915	CcSEcCtD
Neostigmine—Abdominal pain—Sorafenib—liver cancer	0.00745	0.0091	CcSEcCtD
Neostigmine—Osteoarthritis—Epirubicin—liver cancer	0.00709	0.00866	CcSEcCtD
Neostigmine—Hypersensitivity—Sorafenib—liver cancer	0.00694	0.00848	CcSEcCtD
Neostigmine—Asthenia—Sorafenib—liver cancer	0.00676	0.00826	CcSEcCtD
Neostigmine—Cardiac arrest—Epirubicin—liver cancer	0.00674	0.00823	CcSEcCtD
Neostigmine—Pruritus—Sorafenib—liver cancer	0.00667	0.00815	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—liver cancer	0.00656	0.00801	CcSEcCtD
Neostigmine—Diarrhoea—Sorafenib—liver cancer	0.00645	0.00788	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—liver cancer	0.00624	0.00762	CcSEcCtD
Neostigmine—Dizziness—Sorafenib—liver cancer	0.00623	0.00761	CcSEcCtD
Neostigmine—Vomiting—Sorafenib—liver cancer	0.00599	0.00732	CcSEcCtD
Neostigmine—Rash—Sorafenib—liver cancer	0.00594	0.00726	CcSEcCtD
Neostigmine—Dermatitis—Sorafenib—liver cancer	0.00594	0.00725	CcSEcCtD
Neostigmine—Headache—Sorafenib—liver cancer	0.0059	0.00721	CcSEcCtD
Neostigmine—Pollakiuria—Epirubicin—liver cancer	0.00566	0.00691	CcSEcCtD
Neostigmine—Nausea—Sorafenib—liver cancer	0.0056	0.00684	CcSEcCtD
Neostigmine—Drowsiness—Epirubicin—liver cancer	0.00546	0.00667	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—liver cancer	0.00524	0.0064	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—liver cancer	0.00505	0.00617	CcSEcCtD
Neostigmine—Bradycardia—Epirubicin—liver cancer	0.00499	0.0061	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—liver cancer	0.00484	0.00592	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—liver cancer	0.00482	0.00589	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—liver cancer	0.00481	0.00587	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—liver cancer	0.00462	0.00564	CcSEcCtD
Neostigmine—Flushing—Epirubicin—liver cancer	0.00455	0.00556	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—liver cancer	0.00448	0.00547	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—liver cancer	0.00446	0.00545	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—liver cancer	0.00445	0.00543	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—liver cancer	0.00442	0.0054	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—liver cancer	0.00438	0.00535	CcSEcCtD
Neostigmine—Mental disorder—Epirubicin—liver cancer	0.0043	0.00525	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—liver cancer	0.00421	0.00514	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—liver cancer	0.00421	0.00514	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—liver cancer	0.0041	0.00501	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—liver cancer	0.00409	0.005	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—liver cancer	0.00405	0.00495	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—liver cancer	0.00397	0.00486	CcSEcCtD
Neostigmine—Agitation—Epirubicin—liver cancer	0.00392	0.00479	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—liver cancer	0.00389	0.00475	CcSEcCtD
Neostigmine—Syncope—Epirubicin—liver cancer	0.00383	0.00468	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—liver cancer	0.0038	0.00464	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—liver cancer	0.00375	0.00458	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—liver cancer	0.0037	0.00452	CcSEcCtD
Neostigmine—Arthralgia—Epirubicin—liver cancer	0.00363	0.00444	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—liver cancer	0.00363	0.00443	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00361	0.00441	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—liver cancer	0.00355	0.00434	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—liver cancer	0.00354	0.00433	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—liver cancer	0.00348	0.00426	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—liver cancer	0.00347	0.00424	CcSEcCtD
Neostigmine—Shock—Epirubicin—liver cancer	0.00343	0.00419	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—liver cancer	0.00342	0.00418	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—liver cancer	0.00342	0.00417	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—liver cancer	0.0034	0.00415	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—liver cancer	0.00338	0.00413	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—liver cancer	0.00337	0.00411	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—liver cancer	0.00336	0.00411	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00334	0.00408	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—liver cancer	0.00329	0.00402	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—liver cancer	0.00325	0.00398	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—liver cancer	0.00322	0.00394	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00317	0.00388	CcSEcCtD
Neostigmine—Shock—Doxorubicin—liver cancer	0.00317	0.00387	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—liver cancer	0.00316	0.00386	CcSEcCtD
Neostigmine—Insomnia—Epirubicin—liver cancer	0.00315	0.00385	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—liver cancer	0.00315	0.00384	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—liver cancer	0.00313	0.00382	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—liver cancer	0.00312	0.00381	CcSEcCtD
Neostigmine—Dyspnoea—Epirubicin—liver cancer	0.00311	0.00379	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—liver cancer	0.0031	0.00378	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—liver cancer	0.00301	0.00368	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00301	0.00367	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00294	0.00359	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—liver cancer	0.00292	0.00356	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—liver cancer	0.00287	0.00351	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—liver cancer	0.00287	0.0035	CcSEcCtD
Neostigmine—Gastrointestinal pain—Epirubicin—liver cancer	0.00285	0.00348	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00278	0.0034	CcSEcCtD
Neostigmine—Urticaria—Epirubicin—liver cancer	0.00277	0.00338	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—liver cancer	0.00275	0.00336	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00264	0.00322	CcSEcCtD
Neostigmine—Hypersensitivity—Epirubicin—liver cancer	0.00257	0.00314	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—liver cancer	0.00256	0.00313	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—liver cancer	0.00255	0.00311	CcSEcCtD
Neostigmine—Asthenia—Epirubicin—liver cancer	0.0025	0.00305	CcSEcCtD
Neostigmine—Pruritus—Epirubicin—liver cancer	0.00246	0.00301	CcSEcCtD
Neostigmine—Diarrhoea—Epirubicin—liver cancer	0.00238	0.00291	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—liver cancer	0.00237	0.0029	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—liver cancer	0.00231	0.00283	CcSEcCtD
Neostigmine—Dizziness—Epirubicin—liver cancer	0.0023	0.00281	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—liver cancer	0.00228	0.00279	CcSEcCtD
Neostigmine—Vomiting—Epirubicin—liver cancer	0.00221	0.00271	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—liver cancer	0.00221	0.00269	CcSEcCtD
Neostigmine—Rash—Epirubicin—liver cancer	0.0022	0.00268	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—liver cancer	0.00219	0.00268	CcSEcCtD
Neostigmine—Headache—Epirubicin—liver cancer	0.00218	0.00267	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—liver cancer	0.00213	0.0026	CcSEcCtD
Neostigmine—Nausea—Epirubicin—liver cancer	0.00207	0.00253	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—liver cancer	0.00205	0.0025	CcSEcCtD
Neostigmine—Rash—Doxorubicin—liver cancer	0.00203	0.00248	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—liver cancer	0.00203	0.00248	CcSEcCtD
Neostigmine—Headache—Doxorubicin—liver cancer	0.00202	0.00247	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—liver cancer	0.00191	0.00234	CcSEcCtD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	0.00148	0.00816	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—GLUL—liver cancer	0.00146	0.00803	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00145	0.00801	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00143	0.0079	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00143	0.00786	CbGpPWpGaD
Neostigmine—ACHE—Monoamine Transport—TNF—liver cancer	0.0014	0.00772	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—ADAMTS17—liver cancer	0.00138	0.00762	CbGpPWpGaD
Neostigmine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00132	0.00729	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00128	0.00705	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.00121	0.00667	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—YIF1A—liver cancer	0.00117	0.00647	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—CCND1—liver cancer	0.00115	0.00633	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—JUN—liver cancer	0.00115	0.00632	CbGpPWpGaD
Neostigmine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00109	0.00602	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—MAPK8—liver cancer	0.00108	0.00598	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL12B—liver cancer	0.00106	0.00586	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—YIF1A—liver cancer	0.00105	0.00578	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—EXOSC2—liver cancer	0.000968	0.00533	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.000963	0.00531	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000937	0.00516	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000924	0.00509	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000891	0.00491	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—EXOSC2—liver cancer	0.000863	0.00476	CbGpPWpGaD
Neostigmine—ACHE—Peptide hormone metabolism—CTNNB1—liver cancer	0.00085	0.00468	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CG—liver cancer	0.000849	0.00468	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000833	0.00459	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000833	0.00459	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000825	0.00454	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000814	0.00449	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000804	0.00443	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000795	0.00438	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000791	0.00436	CbGpPWpGaD
Neostigmine—BCHE—Peptide hormone metabolism—CTNNB1—liver cancer	0.000758	0.00418	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CG—liver cancer	0.000757	0.00417	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CD—liver cancer	0.000746	0.00411	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000706	0.00389	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—IL6—liver cancer	0.000693	0.00382	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000692	0.00381	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000681	0.00375	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—UGDH—liver cancer	0.000679	0.00374	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CD—liver cancer	0.000666	0.00367	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000654	0.00361	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CB—liver cancer	0.00065	0.00358	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—EPT1—liver cancer	0.000639	0.00352	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000633	0.00349	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000621	0.00342	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000608	0.00335	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000608	0.00335	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—UGDH—liver cancer	0.000606	0.00334	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TAT—liver cancer	0.000606	0.00334	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000596	0.00328	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.000593	0.00327	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CB—liver cancer	0.00058	0.0032	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000579	0.00319	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—EPT1—liver cancer	0.00057	0.00314	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—ATF3—liver cancer	0.000543	0.00299	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TAT—liver cancer	0.00054	0.00298	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000531	0.00293	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.000529	0.00291	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000514	0.00283	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.000495	0.00273	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—ATF3—liver cancer	0.000485	0.00267	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000471	0.00259	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000465	0.00256	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000461	0.00254	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000456	0.00251	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—BRAF—liver cancer	0.000454	0.0025	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000449	0.00247	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000448	0.00247	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000446	0.00246	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000445	0.00245	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.000442	0.00243	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000434	0.00239	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000427	0.00235	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000424	0.00234	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CPT1B—liver cancer	0.000412	0.00227	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GLUL—liver cancer	0.000412	0.00227	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000408	0.00225	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000407	0.00224	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000407	0.00224	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL2—liver cancer	0.000406	0.00224	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—BRAF—liver cancer	0.000405	0.00223	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000399	0.0022	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000398	0.00219	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NR1H4—liver cancer	0.000397	0.00219	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—liver cancer	0.000396	0.00218	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000391	0.00216	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA3—liver cancer	0.00039	0.00215	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00039	0.00215	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00039	0.00215	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—RAF1—liver cancer	0.000379	0.00209	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000369	0.00203	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CPT1B—liver cancer	0.000367	0.00202	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GLUL—liver cancer	0.000367	0.00202	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.00036	0.00198	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000359	0.00198	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA4—liver cancer	0.000357	0.00197	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NR1H4—liver cancer	0.000354	0.00195	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—liver cancer	0.000354	0.00195	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00035	0.00193	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000349	0.00192	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA3—liver cancer	0.000348	0.00192	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA2—liver cancer	0.000348	0.00192	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—VEGFA—liver cancer	0.000345	0.0019	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—RAF1—liver cancer	0.000338	0.00186	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGF2—liver cancer	0.000337	0.00185	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA1—liver cancer	0.000336	0.00185	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000335	0.00185	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000333	0.00183	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NAT2—liver cancer	0.000332	0.00183	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000319	0.00176	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA4—liver cancer	0.000318	0.00175	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDOB—liver cancer	0.000318	0.00175	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TGFB1—liver cancer	0.000317	0.00175	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000311	0.00171	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA2—liver cancer	0.00031	0.00171	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000307	0.00169	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000306	0.00168	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CRABP1—liver cancer	0.000303	0.00167	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000301	0.00166	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF2—liver cancer	0.0003	0.00165	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA1—liver cancer	0.000299	0.00165	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NAT2—liver cancer	0.000296	0.00163	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TNF—liver cancer	0.000296	0.00163	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UGDH—liver cancer	0.000296	0.00163	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000296	0.00163	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000285	0.00157	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000285	0.00157	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDOB—liver cancer	0.000284	0.00156	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—EPT1—liver cancer	0.000278	0.00153	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000273	0.00151	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000273	0.0015	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CRABP1—liver cancer	0.000271	0.00149	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HPGDS—liver cancer	0.000265	0.00146	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000264	0.00145	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TAT—liver cancer	0.000264	0.00145	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000254	0.0014	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.00025	0.00138	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—F2—liver cancer	0.000247	0.00136	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000244	0.00134	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000243	0.00134	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.00024	0.00132	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000237	0.00131	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HPGDS—liver cancer	0.000237	0.0013	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PSMD10—liver cancer	0.000236	0.0013	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PSMA4—liver cancer	0.000236	0.0013	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000235	0.0013	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GOT2—liver cancer	0.00023	0.00127	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000224	0.00123	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—F2—liver cancer	0.00022	0.00121	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2E1—liver cancer	0.000216	0.00119	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000214	0.00118	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000212	0.00117	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PSMA4—liver cancer	0.000211	0.00116	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PSMD10—liver cancer	0.000211	0.00116	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000209	0.00115	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP2—liver cancer	0.000209	0.00115	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—HRAS—liver cancer	0.000209	0.00115	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GOT2—liver cancer	0.000205	0.00113	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000205	0.00113	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYCS—liver cancer	0.000202	0.00111	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000201	0.00111	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GOT1—liver cancer	0.000199	0.00109	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GGT1—liver cancer	0.000199	0.00109	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000195	0.00108	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000195	0.00107	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000193	0.00107	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2E1—liver cancer	0.000193	0.00106	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000189	0.00104	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000188	0.00104	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000187	0.00103	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP2—liver cancer	0.000187	0.00103	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—HRAS—liver cancer	0.000186	0.00103	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000184	0.00102	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYCS—liver cancer	0.00018	0.000994	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CPT1B—liver cancer	0.000179	0.000987	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GLUL—liver cancer	0.000179	0.000987	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—liver cancer	0.000178	0.000983	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GGT1—liver cancer	0.000177	0.000976	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GOT1—liver cancer	0.000177	0.000976	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMOX1—liver cancer	0.000176	0.000969	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NR1H4—liver cancer	0.000173	0.000952	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.00017	0.000938	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA3—liver cancer	0.00017	0.000936	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—liver cancer	0.000164	0.000903	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000163	0.000901	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CTNNB1—liver cancer	0.00016	0.000884	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—liver cancer	0.000159	0.000877	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMOX1—liver cancer	0.000157	0.000864	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000157	0.000863	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000156	0.000861	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA4—liver cancer	0.000155	0.000856	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1A1—liver cancer	0.000155	0.000856	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA2—liver cancer	0.000151	0.000834	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—liver cancer	0.000146	0.000805	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA1—liver cancer	0.000146	0.000805	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000146	0.000804	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTHFR—liver cancer	0.000145	0.000798	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000145	0.000798	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NAT2—liver cancer	0.000144	0.000796	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CTNNB1—liver cancer	0.000143	0.000788	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARA—liver cancer	0.000142	0.000783	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1A1—liver cancer	0.000139	0.000764	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDOB—liver cancer	0.000138	0.000763	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000133	0.000733	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CRABP1—liver cancer	0.000132	0.000728	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000132	0.000728	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTHFR—liver cancer	0.000129	0.000712	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000129	0.000709	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000128	0.000703	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARA—liver cancer	0.000127	0.000698	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—liver cancer	0.000122	0.00067	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARG—liver cancer	0.000117	0.000647	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HPGDS—liver cancer	0.000115	0.000636	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000114	0.000627	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000109	0.000599	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—liver cancer	0.000109	0.000598	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—liver cancer	0.000107	0.000589	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—liver cancer	0.000106	0.000582	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARG—liver cancer	0.000105	0.000577	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PSMD10—liver cancer	0.000103	0.000567	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PSMA4—liver cancer	0.000103	0.000567	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GOT2—liver cancer	0.0001	0.000552	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	9.81e-05	0.000541	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—liver cancer	9.54e-05	0.000526	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—liver cancer	9.42e-05	0.000519	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2E1—liver cancer	9.41e-05	0.000519	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—liver cancer	9.32e-05	0.000514	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	8.88e-05	0.000489	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYCS—liver cancer	8.81e-05	0.000485	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GOT1—liver cancer	8.64e-05	0.000476	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GGT1—liver cancer	8.64e-05	0.000476	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—liver cancer	8.32e-05	0.000458	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—liver cancer	7.76e-05	0.000428	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMOX1—liver cancer	7.66e-05	0.000422	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—liver cancer	7.13e-05	0.000393	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1A1—liver cancer	6.76e-05	0.000373	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTHFR—liver cancer	6.3e-05	0.000347	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARA—liver cancer	6.18e-05	0.000341	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—liver cancer	5.68e-05	0.000313	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—liver cancer	5.3e-05	0.000292	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARG—liver cancer	5.11e-05	0.000282	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—liver cancer	5.07e-05	0.000279	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—liver cancer	4.66e-05	0.000257	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—liver cancer	4.64e-05	0.000256	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—liver cancer	4.6e-05	0.000253	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—liver cancer	4.14e-05	0.000228	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—liver cancer	4.06e-05	0.000224	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—liver cancer	2.47e-05	0.000136	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—liver cancer	2.02e-05	0.000111	CbGpPWpGaD
